Internal Medicine, Gastroenterology · Framingham, MA
NPI
1538165055
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
43 Lincoln St
Framingham, MA, 01702
Phone (508) 872-0508
Groups this clinician bills Medicare through
Medicare paid, 2024
$184K
1,705 services
Medicare patients, 2024
699
Average age 71
Drug cost, 2024
$1.3M
3,295 prescriptions
Company payments, 2025
$1,084
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Khalid Aziz was code 99214 (office e&m - established), 850 times for 452 patients. In total Khalid Aziz billed 1,705 services in 44 codes, and Medicare paid $184K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 850 | 452 | $96.98 | $82K |
| 43239 Upper GI Endoscopy | Facility | 209 | 198 | $87.90 | $18K |
| 45385 Colonoscopy - Lesion Removal | Facility | 113 | 111 | $184.91 | $21K |
| 99204 Office E&M - New | Office | 105 | 105 | $128.57 | $14K |
| 45380 Lower GI Endoscopy - Other | Facility | 78 | 78 | $125.92 | $9,822 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 49 | 47 | $4.06 | $199 |
| 99223 Hospital E&M - Initial | Facility | 40 | 40 | $135.78 | $5,431 |
| 91065 Test - Miscellaneous | Office | 32 | 20 | $44.87 | $1,436 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 26 | 26 | $182.41 | $4,743 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 18 | 18 | $178.37 | $3,211 |
| 43262 Upper GI Endoscopy | Facility | 18 | 18 | $39.63 | $713 |
| 99202 Office E&M - New | Office | 16 | 16 | $40.93 | $655 |
| 99213 Office E&M - Established | Office | 15 | 14 | $76.94 | $1,154 |
| 45378 Lower GI Endoscopy - Other | Facility | 15 | 15 | $143.26 | $2,149 |
| 43274 Upper GI Endoscopy | Facility | 12 | 11 | $328.60 | $3,943 |
By year: 2022 $209K for 1,743 services; 2023 $200K for 1,777 services; 2024 $184K for 1,705 services.
Medicare prescription drug claims, 2024
In 2024, the drug Khalid Aziz prescribed most often to Medicare patients was Omeprazole, with 815 prescriptions and refills. In total Khalid Aziz wrote 3,295 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 815 | 1,674 | 220 | $13K |
| Famotidine Generic | 399 | 887 | 113 | $5,136 |
| Pantoprazole Sodium Generic | 326 | 735 | 86 | $4,323 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 238 | 315 | 231 | $3,812 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 227 | 227 | 220 | $14K |
| Linzess Linaclotide | 217 | 235 | 43 | $126K |
| Ibsrela Tenapanor Hcl | 82 | 93 | 15 | $166K |
| Voquezna Vonoprazan Fumarate | 80 | 80 | 30 | $51K |
| Sucralfate Generic | 70 | 112 | 20 | $6,087 |
| Dicyclomine Hcl Generic | 62 | 118 | 24 | $1,207 |
| Metoclopramide Hcl Generic | 42 | 44 | 11 | $285 |
| Dexlansoprazole Dr Dexlansoprazole | 33 | 51 | Under 11 | $8,478 |
| Xifaxan Rifaximin | 31 | 39 | 16 | $138K |
| Esomeprazole Magnesium Generic | 30 | 60 | Under 11 | $1,247 |
| Sucraid Sacrosidase | 29 | 29 | Under 11 | $396K |
Brand drugs: 675 claims; generic drugs: 2,620 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Khalid Aziz $1,084 ($1,084 in general payments such as food, travel and fees) from 6 companies. The largest payer was Phathom Pharmaceuticals, Inc. with $509.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.